Loading data for SOLV — first visit, this takes a few seconds.

알림

Solventum Corporation (SOLV)

NYSE: SOLV · 실시간 가격 · USD

91.53

-0.08 (-0.09%)

종가 기준: Aug 27, 2026, 9:52 AM

주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.

-0.09% (1D)

매수호가	91.68
시가총액	15.54B
매출 (ttm)	8.31B
순이익 (ttm)	1.43B
	0.67
	8.18
	11.16
	12.64
P/B (ttm)	3.24
P/S (ttm)	1.87
실적 발표일	Nov 5, 2026

매도호가	93.91
거래량	1,014,660
평균 거래량 (20일)	1,555,526
시가	91.48
전일 종가	91.61
일중 범위	91.16 - 92.71
52주 범위	62.38 - 92.71
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

SOLV 소개

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I...

[더 보기]

산업 Medical Instruments & Supplies

섹터 Healthcare

IPO 일자 Mar 26, 2024

직원 수 20,584

상장 거래소 NYSE

티커 SOLV

웹사이트 https://www.solventum.com

전체 기업 정보

재무 실적

2025년 Solventum의 매출은 8.32B로, 전년 8.25B 대비 0.86% 증가했습니다. 순이익은 1.56B로, 224.84% 증가했습니다.

재무제표

어닝 서프라이즈

Solventum가 Aug 5, 2026에 분기 실적을 발표했습니다:

매출 $2.21B 예상치 하회 $0, 및 2.22% 전년 대비 성장.
EPS 2.55 예상치 상회 0.64, 및 50.89% 전년 대비 성장.

다음 실적 발표

Solventum Corporation의 실적 발표 예정일은 Nov 5, 2026, 정규장 중입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

6일 전 · StockStory

1 Healthcare Stock for Long-Term Investors and 2 Facing Challenges

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare st...

1주 전 · Zacks

SOLV Plans Health Information Systems Business Spinoff to Drive Growth

Solventum plans to spin off its $1.4B HIS business, sharpening its MedTech focus while giving HIS more flexibility to pursue growth.

1주 전 · Barchart

Are Wall Street Analysts Bullish on Solventum Stock?

Solventum has underperformed the broader market, while analysts remain moderately optimistic about its future prospects.

2주 전 · Motley Fool

Solventum (SOLV) Q2 2026 Earnings Call Transcript

CEO Hanson discusses HIS separation strategy and $2.2B in quarterly sales growth.

2주 전 · StockStory

SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook

Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 2.2% year on year to $2.21 billion. Its non-GAAP profit of $2.55 pe...

2 페이지 중 1

Solventum Corporation (SOLV)